Elevation of serum copper levels discriminates Alzheimer's disease from vascular dementia

被引：37
|
作者：
Squitti, R [1 ]
Pasqualetti, P
Cassetta, E
Dal Forno, G
Cesaretti, S
Pedace, F
Finazzi-Agrò, A
Rossini, PM
机构：
[1] AFaR Osped Fatebenefratelli, Dept Neurosci, I-00186 Rome, Italy
[2] Univ Campus Biomed, Neurol Clin, Rome, Italy
[3] Johns Hopkins Univ, Dept Neurol, Sch Med, Baltimore, MD 21218 USA
[4] Univ Roma Tor Vergata, Dept Expt Med, Rome, Italy
[5] Ctr S Giovanni Dio FBF, IRCCS, Brescia, Italy
来源：
NEUROLOGY | 2003年 / 60卷 / 12期
关键词：
D O I：
10.1212/01.WNL.0000068013.27968.29
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2013 / 2014
页数：3
相关论文
共 50 条
  • [21] BIOMARKERS OF ALZHEIMER'S DISEASE AND VASCULAR DEMENTIA SIMULTANEOUSLY SAMPLED FROM SERUM AND CEREBROSPINAL FLUID
    Karadas, Omer
    Koc, Guray
    Ozon, Akcay Ovunc
    Ozturk, Bilgin
    Konukoglu, Dildar
    TURKISH JOURNAL OF GERIATRICS-TURK GERIATRI DERGISI, 2017, 20 (01): : 1 - 7
  • [22] Vascular Function in Alzheimer's Disease and Vascular Dementia
    Tachibana, Hisatsugu
    Washida, Kazuo
    Kowa, Hisatomo
    Kanda, Fumio
    Toda, Tatsushi
    AMERICAN JOURNAL OF ALZHEIMERS DISEASE AND OTHER DEMENTIAS, 2016, 31 (05): : 437 - 442
  • [23] Midline cerebral morphometry discriminates frontotemporal dementia and Alzheimer's disease
    Kaufer, D
    Itti, L
    Miller, B
    Fairbanks, L
    Li, J
    Fishman, J
    Cummings, J
    NEUROLOGY, 1996, 46 (02) : 2061 - 2061
  • [24] Serum Homocysteine, Dehydroepiandrosterone Sulphate and Lipoprotein (a) in Alzheimer's Disease and Vascular Dementia
    Ray, Lopamudra
    Khemka, Vineet Kumar
    Behera, Prajna
    Bandyopadhyay, Kausik
    Pal, Sandip
    Pal, Keya
    Basu, Debasis
    Chakrabarti, Sasanka
    AGING AND DISEASE, 2013, 4 (02): : 57 - 64
  • [25] Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
    György Paragh
    Petra Balla
    Evelin Katona
    Ildikó Seres
    Anikó Égerházi
    István Degrell
    European Archives of Psychiatry and Clinical Neuroscience, 2002, 252 : 63 - 67
  • [26] Serum paraoxonase activity changes in patients with Alzheimer's disease and vascular dementia
    Paragh, G
    Balla, P
    Katona, E
    Seres, I
    Égerházi, A
    Degrell, I
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2002, 252 (02) : 63 - 67
  • [27] Neurosteroids: Cerebrospinal fluid levels for Alzheimer's disease and vascular dementia diagnostics
    Kim, SB
    Hill, M
    Kwak, YT
    Hampl, R
    Jo, DH
    Morfin, R
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2003, 88 (11): : 5199 - 5206
  • [28] A diagnostic dilemma:: is "Alzheimer's dementia" Alzheimer's disease, vascular dementia, or both?
    Román, GC
    Royall, DR
    LANCET NEUROLOGY, 2004, 3 (03): : 141 - 141
  • [29] Serum BDNF, TNF-α and IL-1β levels in dementia patients -: Comparison between Alzheimer's disease and vascular dementia
    Yasutake, Chie
    Kuroda, Kenji
    Yanagawa, Toshio
    Okamura, Takehiko
    Yoneda, Hiroshi
    EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE, 2006, 256 (07) : 402 - U1
  • [30] Cerebrospinal fluid amyloidβ42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia
    de Jong, Danielle
    Jansen, Rene W. M. M.
    Kremer, Berry P. H.
    Verbeek, Marcel M.
    JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES, 2006, 61 (07): : 755 - 758
12345